Immune Score Based Radiomics in Nasopharyngeal Carcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Immune Score Based Radiomics in Nasopharyngeal Carcinoma — Stella

Recruiting

Back to Nasopharyngeal Carcinoma trials

Trial locations(5 sites)

China

Renmin Hospital of Wuhan University, Wuhan, Hubei

Ningbo First Hospital, Ningbo, Ningbo

Ningbo Medical Center Lihuili Hospital, Ningbo, Ningbo

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Wenzhou

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Key details

Sponsor

Zhejiang Cancer Hospital

Collaborators

Renmin Hospital of Wuhan University, First Affiliated Hospital of Wenzhou Medical University

Enrollment target

~494 participants

Started

November 2021

Primary completion

October 2022

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated November 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov